One in three patients with cirrhosis from alcohol recovered after quitting — here’s what predicts who will
STUDY: Hofer BS et al, J Hepatol 2026
STUDY TYPE: Observational cohort study
FUNDING: Independent
Background
We’ve long known that abstinence helps in alcohol-related liver disease, but hard numbers on how much recovery is possible — and who achieves it — have been missing.
The Study
This multicenter retrospective study followed 633 patients with decompensated alcohol-related cirrhosis across 17 hospitals in Asia and Europe who had stopped drinking. Median age was 55. Researchers tracked liver recovery — defined by resolved symptoms, medication discontinuation, and no serious bleeding for a year — over a median follow-up of 36 months.
31% of patients achieved full hepatic recovery. Recovery rates rose steadily: 12% at 1 year, 29% at 3 years, and 34% at 5 years — recovery kept accumulating long after the 6-month mark where prior studies had shown a plateau. Those who recovered and stayed abstinent had an 80% lower risk of death from any cause, and none died of liver-related causes or developed liver cancer.
Three predictors improved recovery odds: quitting within the first month of diagnosis, fewer complications at presentation, and — counterintuitively — higher transaminase levels, which appear to signal residual viable liver tissue capable of regenerating. Of patients who recovered but resumed drinking, 29% subsequently died.
Practice Implications
- When patients face decompensated cirrhosis — ascites, encephalopathy, bleeding — tell them there’s roughly a 1 in 3 chance of meaningful liver recovery if they completely stop drinking. Simply lowering alcohol is not enough.
- The earlier they quit after diagnosis, the better their odds.
- Elevated transaminases aren’t just a bad sign — they may indicate the liver still has something to work with.
— Chris Aiken, MD
Director, Psych Partners
Editor in Chief, Carlat Psychiatry Report







